Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

Milan, Milano 20122

0 studies enrolling now · 6 studies all time

What they study most

Celiac Disease, Cirrhosis, Liver, Hemophilia B, Hemophilia a, Myelofibrosis, NASH, NASH - Nonalcoholic Steatohepatitis, Resectable Non-small Cell Lung Cancer

Studies at this site

• A Trial to Learn if the Combination of Fianlimab, Cemiplimab, and Chemotherapy is Safe and Works Better Than the Combination of Cemiplimab and Chemotherapy in Adult Patients With Non-Small Cell Lung Cancer That Can be Treated With Surgery — Running, not enrolling
• A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor Treatment — Running, not enrolling
• A Phase 3 Study to Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NASH Cirrhosis (MAESTRO-NASH-OUTCOMES) — Running, not enrolling
• A Phase 3 Study to Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis — Running, not enrolling
• A Study of TAK-062 in Treatment of Active Celiac Disease in Participants Attempting a Gluten-Free Diet — Completed
• Hemophilia Non-Interventional Study Prior to SerpinPC Intervention (PRESent-5) — Stopped early